Friday, July 19, 2024
Thursday, July 18, 2024
ADAP AS OF 7/18/2024 FILL THE SHORT STUDY
| ID | STOCK | REMARK PRICE | BROKER | DATE AND TIME | PRICES | AMOUNT | Field1 | number | fill prices | fill dollar | total filled | total unit | average | NET LOSS | Field2 | REMARK |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 307 | ADAP | RH | 7/18/2024 | $1.84 | 10 | $18.40 | 100 | $1.20 | $120.00 | $138.40 | 110 | $1.26 | 0 |
Business Summary
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.
It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers.
The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
ACST 80% DOWN FILL THE SHORT 1:1000 AS OF 7/18/2024
| ID | STOCK | REMARK PRICE | BROKER | DATE AND TIME | PRICES | AMOUNT | Field1 | number | fill prices | fill dollar | total filled | total unit | average | NET LOSS | Field2 | REMARK |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 271 | ACST | RH | 7/18/2024 | $22.01 | 1 | $22.01 | 1000 | $2.95 | $2,950.00 | $2,972.01 | 1001 | $2.97 | 0 |
ACIU AS OF 7/18/2024 FILL THE SHORT RH
| ID | STOCK | REMARK PRICE | BROKER | DATE AND TIME | PRICES | AMOUNT | Field1 | number | fill prices | fill dollar | total filled | total unit | average | NET LOSS | Field2 | REMARK |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 283 | ACIU | RH | 7/18/2024 | $4.04 | 4 | $16.16 | 40 | $3.63 | $145.20 | $161.36 | 44 | $3.67 | 0 |
Monday, July 1, 2024
Tuesday, June 18, 2024
Sunday, June 16, 2024
ChatGPT’s Creator is Betting Big on This “Limitless Energy” Breakthrough
ChatGPT’s Creator is Betting Big on This “Limitless Energy” Breakthrough
For a moment, imagine a world of limitless energy – a world where there’s so much energy produced that everyone, everywhere, can power their homes, apartments, and offices at all hours of the day, with just pennies.
These days, it’s tough to imagine a world like that. Last winter, for example, the average U.S. heating bill exceeded $1,000.
But thanks to a potentially world-changing scientific breakthrough that was recently announced, the ostensibly utopian world of limitless energy could soon become a reality.
Prescient investors stand to make fortunes in this limitless energy breakthrough.
That’s why both Microsoft (MSFT) – the world’s second most valuable company – and ChatGPT’s creator Sam Altman are both betting big on this very limitless energy breakthrough right now.
In fact, Microsoft recently announced a huge deal to start buying a ton of this limitless energy as soon as 2028.
Interested? You should be…
We’re talking about arguably the biggest scientific breakthrough of our lifetimes, and maybe the biggest investment opportunity of our lifetimes, too.
Thursday, June 6, 2024
Thursday, May 30, 2024
Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
VSTM crashed
Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
Wednesday, May 29, 2024
Tuesday, April 30, 2024
Saturday, April 13, 2024
The Dogecoin (DOGE) market has experienced a decline recently. Here are some reasons behind this downward trend:
The Dogecoin (DOGE) market has experienced a decline recently. Here are some reasons behind this downward trend:
Market Correction: The broader crypto market has undergone a sharp correction, affecting various cryptocurrencies, including Dogecoin. Over the last 24 hours, DOGE’s price has dropped by 5.5%, reaching an intraday low of $0.1712 on April 3. This underperformance contrasts with the overall crypto market, which fell by approximately 0.17% during the same period1.
Profit-Taking: After recent gains, investors may be taking profits from their Dogecoin holdings. When prices rise significantly, some traders choose to sell their assets to lock in gains. This profit-taking behavior can lead to downward pressure on prices2.
Futures Open Interest Decline: Data indicates that Dogecoin’s futures open interest (OI) has fallen by 27.6% from $2.21 billion on March 28 to the current value of $1.60 billion. A decrease in OI can impact market sentiment and contribute to price declines1.
Market Sentiment: The overall market sentiment plays a crucial role. Factors such as economic data releases, regulatory news, and investor sentiment can influence the demand and supply dynamics of cryptocurrencies, including Dogecoin3.
Remember that cryptocurrency markets are highly volatile, and prices can fluctuate rapidly. It’s essential to stay informed and consider various factors when analyzing market movements. 📉🚀
Thursday, April 11, 2024
GALT
04/03/2024 AND 04/11/2024
| GALT | Your market value $3.80 Today‘s return +$0.50 (+15.00%) Total return +$1.21 (+46.99%) Your average cost $2.35 Shares 1.1 Market cap 228.42M Price-Earnings ratio -5.00 Dividend yield — Average volume 234.38K High today $3.74 Low today $2.98 Open price $2.98 Volume 929.54K 52 Week high $3.74 52 Week low $1.28 |
market value $4.52 Today‘s return +$0.32 (+7.59%) Total return +$1.33 (+41.68%) Your average cost $2.90 Shares 1.1 Portfolio diversity 0.11%Market cap 260.61M Price-Earnings ratio -5.12 Dividend yield — Average volume 342.71K High today $4.28 Low today $3.70 Open price $3.83 Volume 403.74K 52 Week high $4.28 52 Week low $1.28 |
ADAP
as of 4/11/2024
Your market value
$13.11
| Today‘s return | +$0.40 (+3.14%) | |
| Total return | -$5.30 (-28.79%) |
Your average cost
$1.84
| Shares | 10.01 | |
| Portfolio diversity | 0.32% |
Market cap
290.78M
High today
$1.36
52 Week high
$2.05
Price-Earnings ratio
-2.62
Low today
$1.25
52 Week low
$0.42
Dividend yield
Open price
$1.33
Average volume
1.16M
Volume
1.51M
DNMR
fPREVIOUSLY AVG 0.94 $ 44 SHARE
FFILL THE SHORT WITH 0.8891 FOR 57 SHARE
Your market value
$89.69 AS OF 4/11/2024 THURSDAY
| Today‘s return | -$0.5588 (-0.62%) | |
| Total return | -$1.4948 (-1.64%) |
Your average cost
$0.9028
| Shares | 101 | |
| Portfolio diversity | 2.05% |
Subscribe to:
Posts (Atom)